Rank #1173GERN

Geron Corporation

$1.92

-1.03% (Daily)

Market Cap

$1.23B

Revenue

$183.40M

Rank by MCap

#1173

Sector

Healthcare

Industry

Biotechnology

CEO

Ms. Michelle J. Robertson

Headquarters

Foster City, CA

Employees

229

About Geron Corporation

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.